Since located in a putative glycosylation site, the nonsynonymous SNP is potentially involved in the pathophysiology of schizophrenia through affecting the glycosylation status and the transport activity of SLC1A2 [30]. The gene discussed is SLC1A2; the disease is schizophrenia.